ENTPD1 and prostate cancer: The primary objective of this study was to investigate the association between the tissue expressions of CD39 and CD73 and the Gleason score [36], a crucial clinical parameter used in the diagnosis of prostate cancer, the determination of the clinical stage, and therapeutic decision making for prostate cancer.